Literature DB >> 1652756

Human immunodeficiency virus induction of malignant transformation in human B lymphocytes.

J Laurence1, S M Astrin.   

Abstract

Aggressive B-cell lymphomas are occurring with increasing incidence among individuals infected with human immunodeficiency virus (HIV). Several lines of evidence implicate both Epstein-Barr virus (EBV) and c-myc activation in the pathogenesis of a major subset of these tumors. These observations prompted our investigation of interactions among EBV, c-myc, and HIV in primary B cells. We show that nonimmortalized peripheral B lymphocytes from EBV-seropositive, HIV-seronegative donors can be infected by HIV and that a subset of these lymphocytes become transformed. Malignant transformation was documented by several criteria. These cells displayed altered growth properties, propagating in 1% serum and cloning in soft agar, and formed invasive tumors of Burkitt lymphoma phenotype after subcutaneous injection into severe combined immunodeficiency mice. Such cells revealed marked enhancement of EBV DNA and RNA and of endogenous c-myc transcripts and protein. HIV-1 infection of already immortalized B-cell lines led to a similar upregulation of EBV and c-myc transcripts. These data indicate that HIV has properties of a transforming retrovirus, as it mediates two events linked to B-cell neoplasia: deregulation of c-myc and activation of EBV. They also raise the possibility of a role for HIV, apart from induction of immune suppression, in the pathogenesis of B-cell lymphoma in the acquired immune deficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652756      PMCID: PMC52356          DOI: 10.1073/pnas.88.17.7635

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41.

Authors:  N Chirmule; V S Kalyanaraman; C Saxinger; F Wong-Staal; J Ghrayeb; S Pahwa
Journal:  AIDS Res Hum Retroviruses       Date:  1990-03       Impact factor: 2.205

2.  Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma.

Authors:  T H Rabbitts; P H Hamlyn; R Baer
Journal:  Nature       Date:  1983 Dec 22-1984 Jan 4       Impact factor: 49.962

3.  Biological activity of mRNA immobilized on nitrocellulose in NaI.

Authors:  J Bresser; H R Hubbell; D Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

4.  A soluble inhibitor of T lymphocyte function induced by HIV-1 infection of CD4+ T cells: characterization of a cellular protein and its relationship to p15E.

Authors:  J Laurence; J Kulkosky; B Dong; E Early; R Snyderman; G J Cianciolo
Journal:  Cell Immunol       Date:  1990-07       Impact factor: 4.868

5.  Lymphomatoid granulomatosis in the acquired immunodeficiency syndrome. Evidence of Epstein-Barr virus infection and B-cell clonal selection without myc rearrangement.

Authors:  K Mittal; A Neri; H Feiner; R Schinella; F Alfonso
Journal:  Cancer       Date:  1990-03-15       Impact factor: 6.860

6.  Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice.

Authors:  M J Cannon; P Pisa; R I Fox; N R Cooper
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

7.  Neoplastic transformation and tumorigenesis by the human protooncogene MYC.

Authors:  G M Ramsay; G Moscovici; C Moscovici; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates.

Authors:  A Polack; G Hartl; U Zimber; U K Freese; G Laux; K Takaki; B Hohn; L Gissmann; G W Bornkamm
Journal:  Gene       Date:  1984-03       Impact factor: 3.688

9.  Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1.

Authors:  J Laurence; H Cooke; S K Sikder
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

10.  Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies.

Authors:  P G Rothberg; M D Erisman; R E Diehl; U G Rovigatti; S M Astrin
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

View more
  15 in total

1.  Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.

Authors:  M L Hammarskjöld; M C Simurda
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Recovery from retrovirus-induced immune suppression in BDP/J mice: dominance of the "regressor' phenotype.

Authors:  G L Gilmore
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

3.  Computational design optimization for microfluidic magnetophoresis.

Authors:  Brian D Plouffe; Laura H Lewis; Shashi K Murthy
Journal:  Biomicrofluidics       Date:  2011-03-30       Impact factor: 2.800

4.  Detection of abundantly transcribed genes and gene translocation in human immunodeficiency virus-associated non-Hodgkin's lymphoma.

Authors:  V Tarantul; A Nikolaev; H Hannig; B Kalmyrzaev; I Muchoyan; V Maximov; V Nenasheva; V Dubovaya; G Hunsmann; W Bodemer
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

5.  Pediatric AIDS-associated lymphocytic interstitial pneumonia and pulmonary arterio-occlusive disease: role of VCAM-1/VLA-4 adhesion pathway and human herpesviruses.

Authors:  S J Brodie; C de la Rosa; J G Howe; J Crouch; W D Travis; K Diem
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

6.  The antimitotic drug 4,6-dimethyl-2-amino-3,4,5- trimethoxyphenyl-pyrimidine inhibits the nucleoside transport system of cells from various animal species.

Authors:  A Pani; P Obino; P Guarracino; P La Colla
Journal:  Experientia       Date:  1994-01-15

7.  Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein.

Authors:  T C Rodman; S E To; H Hashish; K Manchester
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

8.  Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes.

Authors:  T VandenDriessche; M K Chuah; L Chiang; H K Chang; B Ensoli; R A Morgan
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

Review 9.  HIV infection and lymphoma.

Authors:  K L Grogg; R F Miller; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

10.  Epstein-Barr virus infection in HIV-positive patients.

Authors:  A Telenti; D E Uehlinger; F Marchesi; D Germann; R Malinverni; L Matter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.